{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-144049","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2024-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.116755+00:00","generated_at":"2026-06-01T10:34:14.440117+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Catalyst Pharmaceuticals shareholders elect directors and approve incentive plan amendment","bullets":["All seven director nominees elected: Daly, McEnany, Denkhaus, Harper, O'Keeffe, Thompson, Tierney.","Amendment to 2018 Stock Incentive Plan approved with 86.8M for, 2.9M against, 168k abstained.","Advisory vote on 2023 executive compensation passed: 84.2M for, 5.5M against, 182k abstained.","Ratification of Grant Thornton as independent auditor approved: 99.6M for, 2.0M against, 79k abstained."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-144049","json":"https://secwatch.observer/filing/0001193125-24-144049.json","markdown":"https://secwatch.observer/filing/0001193125-24-144049.md","text":"https://secwatch.observer/filing/0001193125-24-144049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524144049/0001193125-24-144049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524144049/d786039d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T10:34:14.440117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}